卡莫司汀相关性肺炎：一种毒性表现 - Suppr

Suppr

超能文献

BCNU-associated pneumonitis: portrait of a toxicity.

作者信息

Till Brian G, Madtes David K

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

出版信息

Leuk Lymphoma. 2012 Jun;53(6):1019-20. doi: 10.3109/10428194.2011.654341. Epub 2012 Jan 31.

DOI:10.3109/10428194.2011.654341

PMID:22220936

Abstract

摘要

相似文献

BCNU-associated pneumonitis: portrait of a toxicity.卡莫司汀相关性肺炎：一种毒性表现

Leuk Lymphoma. 2012 Jun;53(6):1019-20. doi: 10.3109/10428194.2011.654341. Epub 2012 Jan 31.

Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.大剂量环磷酰胺、BCNU 和依托泊苷化疗后自体干细胞移植后继发肺炎的危险因素。

Leuk Lymphoma. 2012 Jun;53(6):1130-6. doi: 10.3109/10428194.2011.645208. Epub 2012 Jan 3.

Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.达卡巴嗪联合环磷酰胺、卡莫司汀、依托泊苷及自体干细胞移植治疗淋巴瘤和多发性骨髓瘤的Ⅰ期试验

J Clin Oncol. 1994 Sep;12(9):1890-901. doi: 10.1200/JCO.1994.12.9.1890.

High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity study.大剂量卡莫司汀、依托泊苷和美法仑（“BEM”）联合自体干细胞移植：一项剂量-毒性研究。

Bone Marrow Transplant. 1996 Mar;17(3):335-40.

Bone Marrow Transplant. 1999 Jun;23(11):1131-8. doi: 10.1038/sj.bmt.1701790.

Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy.CDEP（环磷酰胺、地塞米松、依托泊苷、顺铂）化疗后的肺毒性综合征

Bone Marrow Transplant. 2001 Aug;28(4):399-403. doi: 10.1038/sj.bmt.1703147.

Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.采用环磷酰胺、卡莫司汀和依托泊苷对中高级别非霍奇金淋巴瘤进行自体移植治疗结果的预后因素

J Clin Oncol. 1993 Jun;11(6):1085-91. doi: 10.1200/JCO.1993.11.6.1085.

High-dose Bendamustine-EAM followed by autologous stem cell rescue results in long-term remission rates in lymphoma patients, without renal toxicity.高剂量苯达莫司汀联合 EAM 方案继以自体干细胞解救治疗可使淋巴瘤患者获得长期缓解，且无肾毒性。

Eur J Haematol. 2018 Sep;101(3):326-331. doi: 10.1111/ejh.13102. Epub 2018 Aug 3.

Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.采用BEAC（卡氮芥、依托泊苷、阿糖胞苷、环磷酰胺）±全身照射及自体骨髓移植治疗恶性淋巴瘤后的溶血性尿毒症综合征和肾功能障碍。

Bone Marrow Transplant. 1993 Mar;11(3):205-8.

Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).与接受环磷酰胺、卡莫司汀和依托泊苷（CBV）方案自体移植的霍奇金病患者相比，非霍奇金淋巴瘤患者移植后骨髓增生异常综合征/急性白血病的发病率。

Leuk Lymphoma. 2001 Feb;40(5-6):499-509. doi: 10.3109/10428190109097649.

引用本文的文献

Evaluation of outcome and safety profile in high-dose BEAM and Benda-EAM chemotherapy with subsequent autologous stem cell transplantation in lymphoma patients.淋巴瘤患者接受大剂量BEAM和Benda-EAM化疗并随后进行自体干细胞移植的疗效及安全性评估。

Contemp Oncol (Pozn). 2024;28(2):158-166. doi: 10.5114/wo.2024.141794. Epub 2024 Jul 26.

Evaluating the Efficacy of Modified BeEAM(Bendamustine, Etoposide, Cytarabine, Melphalan) Regimen as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma: An Experience from Two Centers of a Developing Country.评估改良的BeEAM（苯达莫司汀、依托泊苷、阿糖胞苷、美法仑）方案作为复发或难治性淋巴瘤自体干细胞移植预处理方案的疗效：来自一个发展中国家两个中心的经验。

Int J Hematol Oncol Stem Cell Res. 2023 Apr 1;17(2):106-113. doi: 10.18502/ijhoscr.v17i2.12647.

BeEAM Conditioning including High-Dose Bendamustine before Autologous Stem Cell Transplantation Is Safe and Effective in Patients with Waldenstrom's Macroglobulinemia.在自体干细胞移植前进行包括高剂量苯达莫司汀在内的BeEAM预处理，对华氏巨球蛋白血症患者是安全有效的。

J Clin Med. 2023 Mar 19;12(6):2378. doi: 10.3390/jcm12062378.

BeEAM conditioning regimen is a safe, efficacious and economical alternative to BEAM chemotherapy.BeEAM 预处理方案是替代 BEAM 化疗的一种安全、有效且经济的选择。

Sci Rep. 2021 Jul 7;11(1):14071. doi: 10.1038/s41598-021-93516-x.

Cancers (Basel). 2021 Mar 2;13(5):1052. doi: 10.3390/cancers13051052.

Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients.亚硝脲、依托泊苷和环磷酰胺联合自体干细胞移植治疗儿科淋巴瘤患者。

Int J Hematol. 2020 Jun;111(6):877-887. doi: 10.1007/s12185-020-02863-4. Epub 2020 Mar 26.

Comparable safety profile of BeEAM (bendamustine, etoposide, cytarabine, melphalan) and BEAM (carmustine, etoposide, cytarabine, melphalan) as conditioning before autologous haematopoietic cell transplantation.在自体造血细胞移植前作为预处理方案时，苯达莫司汀、依托泊苷、阿糖胞苷、美法仑（BeEAM）与卡莫司汀、依托泊苷、阿糖胞苷、美法仑（BEAM）具有相似的安全性。

Contemp Oncol (Pozn). 2018;22(2):113-117. doi: 10.5114/wo.2018.77046. Epub 2018 Jun 30.

Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.采用基于福莫司汀的新的高剂量化疗方案治疗复发/难治性霍奇金淋巴瘤患者可改善预后。

Br J Haematol. 2016 Jan;172(1):111-21. doi: 10.1111/bjh.13803. Epub 2015 Oct 12.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验